aplastic anemia | Page 4 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Raoul Tibes, MD, PhD

Tibes, Raoul

As a physician–scientist, Dr. Tibes is grateful for the opportunity to advance treatments for people who have cancer through my own groundbreaking research. He has been involved in developing national treatment guidelines for leukemia, and he has been actively engaged in translational research to identify and develop new leukemia treatments over the last few years. Many of these treatments, which directly target the DNA of cancer cells or push leukemia cells to die, were developed in Dr. Tibes' laboratory and have led to clinical trials and U.S. Food and Drug Administration approvals.

Imad Tabbara, MD

Tabbara, Imad
Professor of Medicine
The George Washington Cancer Center

Imad Tabbara, MD is board-certified in internal medicine, medical oncology, and hematology.  He serves as the director of the Fellowship Training Program with The George Washington University (GWU).  His career has been focused on the treatment of cancer patients, as well as, patients with benign and malignant hematologic disorders.

Jamile M. Shammo, MD, FASCP, FACP

Shammo, Jamile
Professor of Medicine and Pathology
Rush University Medical Center

Dr. Jamile M. Shammo is Associate Professor of Medicine and Pathology, Section of Hematology and Stem Cell Transplantation, Division of Hematology/Oncology, at Rush University Medical Center in Chicago, Illinois, where she spearheads the MDS/MPN/

Evan Shereck, MD, MEd

Shereck, Evan
Associate Professor of Pediatrics, Division of Hematology and Oncology
OHSU Hospital

Dr. Shereck specializes in bone marrow transplantation for children with cancer, blood disorders and immunodeficiencies. She conducts clinical trials as a part of the Primary Immune Deficiency Treatment Consortium (PIDTC) and the Pediatric Blood and Marrow Transplant Consortium (PBMTC).

Sharon Savage, MD

Savage, Sharon
DCEG Clinical Director
National Cancer Institute – Shady Grove

Dr. Savage joined the Clinical Genetics Branch, DCEG, NCI in 2006 as a tenure-track investigator. She was awarded scientific tenure by the NIH and appointed senior investigator in 2012. In 2013, she was promoted to Branch Chief, and in 2018, she became the Clinical Director for DCEG. Dr. Savage received her M.D. from the University of Vermont College of Medicine, completed residency training in Pediatrics at Children’s National Medical Center, in Washington DC, and a fellowship in Pediatric Hematology/Oncology at the NCI Pediatric Oncology Branch and Johns Hopkins University.